+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience



Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience



Transplantation 99(1): 133-138



Kidney transplantation (KT) alone in end-stage renal disease (ESRD) patients with hepatitis B virus liver cirrhosis (LC) is controversial. This study compared outcomes of KT in hepatitis B surface antigen-positive patients with ESRD with (LC group) and without LC (non-LC group). Outcomes were analyzed in 103 hepatitis B surface antigen-positive patients with ESRD who underwent KT alone between 1997 and 2011. Ninety-one were in the non-LC group and 12 were in the LC group. Of the latter, eight were Child-Pugh (CP) class A and four were CP class B. Baseline aspartate transaminase and alanine transaminase levels were higher in the LC group. model for end-stage liver disease (MELD) scores were similar in patients with CP class A and class B, only serum albumin level was lower in CP class B. After KT, one CP class A patient showed an increase in the CP score from 5 to 10 points, MELD score from 22.3 to 44.1 points. The CP and MELD scores of the other 11 patients in the LC group did not increase. All four pre-KT CP class B patients were reclassified as class A after KT because of elevated serum albumin levels. Four patients in the LC group developed hepatocellular carcinoma at a median of 35 months (range, 20-57 months) after KT. The 5-year patient survival rate was similar in the LC and non-LC groups (100% vs. 94%, P=0.15). The incidence of pre-KT LC did not differ between survivors and nonsurvivors (11% vs. 18%, P=0.61). Occurrence of hepatocellular carcinoma was significantly higher in nonsurvivors than in survivors. Kidney transplantation alone may be safe in patients with compensated hepatitis B virus LC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054041523

Download citation: RISBibTeXText

PMID: 24983308

DOI: 10.1097/tp.0000000000000234


Related references

Kidney Transplantation in Korean Patients With End-Stage Renal Disease Aged 65 and Older: A Single-Center Experience. Transplantation Proceedings 49(5): 987-991, 2018

Liver transplantation outcomes in patients with cirrhosis and hepatocellular carcinoma: experience of a single center in a viral hepatitis endemic area. Transplantation Proceedings 39(5): 1508-1510, 2007

Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients. Digestive Diseases and Sciences 61(11): 3346-3353, 2016

Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience. Lupus 26(11): 1157-1165, 2017

Six end-stage renal disease patients benefited from first non-simultaneous single center 6-way kidney exchange transplantation in India. World Journal of Nephrology 5(6): 531-537, 2016

Reconsideration of liver transplantation for portal hypertension due to hepatitis B cirrhosis: a single center experience. Hepato-Gastroenterology 60(123): 496-500, 2013

Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. Journal of Surgical Research 183(2): 936-943, 2013

Risk-benefit point of the model for end-stage liver disease score in patients waiting for deceased-donor liver transplantation: a single-center experience. Hepatology Research 2019, 2019

Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study. Kidney Research and Clinical Practice 2019, 2019

Liver transplantation for primary biliary cirrhosis in a hepatitis endemic region: a single-center Asian experience. Clinical Transplantation 25(1): 47-53, 2011

Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India. Journal of Clinical and Experimental Hepatology 8(2): 116-120, 2018

Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Therapeutic Apheresis and Dialysis 17(4): 363-367, 2014

Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience. Renal Failure 35(10): 1305-1309, 2014

End-stage renal disease after kidney donation: a single-center experience. Transplantation Proceedings 40(5): 1315-1318, 2008

Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience. Transplantation Proceedings 44(1): 77-79, 2012